Objectives Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. Methods We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher's exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. Results COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53-18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10-6.90]). Conclusions There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization.
机构:
Royal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Herrmann, Markus
Sullivan, David R.
论文数: 0引用数: 0
h-index: 0
机构:
Royal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Sullivan, David R.
Veillard, Anne-Sophie
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Veillard, Anne-Sophie
McCorquodale, Thomas
论文数: 0引用数: 0
h-index: 0
机构:
Royal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
McCorquodale, Thomas
Straub, Isabella R.
论文数: 0引用数: 0
h-index: 0
机构:
Royal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Straub, Isabella R.
Scott, Russell
论文数: 0引用数: 0
h-index: 0
机构:
Christchurch Hosp, Christchurch, New ZealandRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Scott, Russell
Laakso, Markku
论文数: 0引用数: 0
h-index: 0
机构:
Univ Eastern Finland, Dept Med, Kuopio, Finland
Kuopio Univ Hosp, SF-70210 Kuopio, FinlandRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Laakso, Markku
Topliss, Duncan
论文数: 0引用数: 0
h-index: 0
机构:
Monash Univ, Dept Med, Melbourne, Vic 3004, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Topliss, Duncan
Jenkins, Alicia J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Jenkins, Alicia J.
Blankenberg, Stefan
论文数: 0引用数: 0
h-index: 0
机构:
Hamburg Heart Ctr, Hamburg, GermanyRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Blankenberg, Stefan
Burton, Anthony
论文数: 0引用数: 0
h-index: 0
机构:
Flinders Med Ctr, Adelaide, SA, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
Burton, Anthony
Keech, Anthony C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, AustraliaRoyal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia
机构:
Harvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USAHarvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USA
Hasegawa, K.
Stewart, C. J.
论文数: 0引用数: 0
h-index: 0
机构:
Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USAHarvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USA
Stewart, C. J.
Celedon, J. C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Div Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USAHarvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USA
Celedon, J. C.
Mansbach, J. M.
论文数: 0引用数: 0
h-index: 0
机构:
Boston Childrens Hosp, Dept Med, Boston, MA USAHarvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USA
Mansbach, J. M.
Tierney, C.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USAHarvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USA
Tierney, C.
Camargo, C. A., Jr.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USAHarvard Med Sch, Dept Emergency Med, Massachusetts Gen Hosp, Boston, MA USA